Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells
[Display omitted] Polymer nanoparticles (NPs) are extensively studied as drug delivery systems for various therapeutic indications, including drug and imaging agent delivery to the brain. Despite intensive research, their toxicological profile has yet to be fully characterized. In particular, the mo...
Gespeichert in:
Veröffentlicht in: | European journal of pharmaceutics and biopharmaceutics 2022-05, Vol.174, p.155-166 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 166 |
---|---|
container_issue | |
container_start_page | 155 |
container_title | European journal of pharmaceutics and biopharmaceutics |
container_volume | 174 |
creator | Tehrani, Soudeh F. Rabanel, Jean-Michel Legeay, Samuel Cayon, Jérôme Riou, Jérémie Saulnier, Patrick Marleau, Sylvie Roullin, V. Gaëlle Hildgen, Patrice Bastiat, Guillaume |
description | [Display omitted]
Polymer nanoparticles (NPs) are extensively studied as drug delivery systems for various therapeutic indications, including drug and imaging agent delivery to the brain. Despite intensive research, their toxicological profile has yet to be fully characterized. In particular, the more subtle effects of nanomaterials on inflammatory processes have scarcely been investigated. Surface properties of NPs are amongst parameters governing interactions between living cells and NPs. They could considerably influence the toxicity and inflammatory response of the cells exposed to NPs.
Polymeric NPs investigated here present a core-shell structure. The core is constituted of hydrophobic poly(lactic acid) (PLA) block and the surface is composed of a shell of hydrophilic block of polyethylene glycol (PEG). The effect of PEG chain length coating on the expression of genes involved in the inflammation response was investigated in two vascular endothelial cell lines (bEnd.3 and HUVEC) by qPCR. Moreover, ROS generation following NP uptake was evaluated.
PEGylated NPs induce a mild and transient activation of inflammatory cytokine and chemokine genes. However, differences in PEG chain length did not show any significant effect on cytokine and chemokine gene expression and PEGylated NPs did not trigger ROS generation.
The present results could contribute significantly to a deeper understanding of nanomaterial interactions and toxicity with vascular endothelial cells, guiding scientists in material coating choices. |
doi_str_mv | 10.1016/j.ejpb.2022.04.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03647377v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939641122000753</els_id><sourcerecordid>2649998153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-6c303d267f902c00239e3e6c7559d583b46f14e0f965ab9f9dda9c53962f0ec03</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVpabZp_0APRcf2YHdkyfIKegkhTQIL7SE9C600arTIlivZC_vvY7NpjjkNzHzvMbxHyGcGNQMmvx9qPIz7uoGmqUHUAPwN2bBtxysuBHtLNqC4qqRg7IJ8KOUAAKJrt-_JBW8F4wL4hvgHE2LKYfhLf9_cnqKZ0NHBDGk0eQo2Ii1z9sYi7ZOb13OhYfDR9L2ZUj7RjGVMQ8FlS4-m2IXJFAeXpkeMwURqMcbykbzzJhb89DwvyZ-fNw_Xd9Xu1-399dWusoKLqZKWA3eN7LyCxgI0XCFHabu2Va7d8r2QngkEr2Rr9sor54yyLVey8YAW-CX5dvZ9NFGPOfQmn3QyQd9d7fS6Ay5Fx7vuyBb265kdc_o3Y5l0H8r6rRkwzUU3UiiltqzlC9qcUZtTKRn9izcDvXahD3rtQq9daBB66WIRfXn2n_c9uhfJ__AX4McZwCWRY8Csiw04WHQho520S-E1_yfNjZs-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2649998153</pqid></control><display><type>article</type><title>Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Tehrani, Soudeh F. ; Rabanel, Jean-Michel ; Legeay, Samuel ; Cayon, Jérôme ; Riou, Jérémie ; Saulnier, Patrick ; Marleau, Sylvie ; Roullin, V. Gaëlle ; Hildgen, Patrice ; Bastiat, Guillaume</creator><creatorcontrib>Tehrani, Soudeh F. ; Rabanel, Jean-Michel ; Legeay, Samuel ; Cayon, Jérôme ; Riou, Jérémie ; Saulnier, Patrick ; Marleau, Sylvie ; Roullin, V. Gaëlle ; Hildgen, Patrice ; Bastiat, Guillaume</creatorcontrib><description>[Display omitted]
Polymer nanoparticles (NPs) are extensively studied as drug delivery systems for various therapeutic indications, including drug and imaging agent delivery to the brain. Despite intensive research, their toxicological profile has yet to be fully characterized. In particular, the more subtle effects of nanomaterials on inflammatory processes have scarcely been investigated. Surface properties of NPs are amongst parameters governing interactions between living cells and NPs. They could considerably influence the toxicity and inflammatory response of the cells exposed to NPs.
Polymeric NPs investigated here present a core-shell structure. The core is constituted of hydrophobic poly(lactic acid) (PLA) block and the surface is composed of a shell of hydrophilic block of polyethylene glycol (PEG). The effect of PEG chain length coating on the expression of genes involved in the inflammation response was investigated in two vascular endothelial cell lines (bEnd.3 and HUVEC) by qPCR. Moreover, ROS generation following NP uptake was evaluated.
PEGylated NPs induce a mild and transient activation of inflammatory cytokine and chemokine genes. However, differences in PEG chain length did not show any significant effect on cytokine and chemokine gene expression and PEGylated NPs did not trigger ROS generation.
The present results could contribute significantly to a deeper understanding of nanomaterial interactions and toxicity with vascular endothelial cells, guiding scientists in material coating choices.</description><identifier>ISSN: 0939-6411</identifier><identifier>EISSN: 1873-3441</identifier><identifier>DOI: 10.1016/j.ejpb.2022.04.003</identifier><identifier>PMID: 35413403</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>bEnd.3 ; Chemical Sciences ; Chemokine ; Cytokine ; Cytokines ; Drug Delivery Systems ; Endothelial Cells - metabolism ; Galenic pharmacology ; HUVEC ; Life Sciences ; Nanoparticles - chemistry ; Particle Size ; PEG-PLA nanoparticle ; Pharmaceutical sciences ; Polyethylene Glycols - chemistry ; Polymers ; Polymers - chemistry ; Reactive Oxygen Species</subject><ispartof>European journal of pharmaceutics and biopharmaceutics, 2022-05, Vol.174, p.155-166</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-6c303d267f902c00239e3e6c7559d583b46f14e0f965ab9f9dda9c53962f0ec03</citedby><cites>FETCH-LOGICAL-c434t-6c303d267f902c00239e3e6c7559d583b46f14e0f965ab9f9dda9c53962f0ec03</cites><orcidid>0000-0001-5393-995X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejpb.2022.04.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35413403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03647377$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Tehrani, Soudeh F.</creatorcontrib><creatorcontrib>Rabanel, Jean-Michel</creatorcontrib><creatorcontrib>Legeay, Samuel</creatorcontrib><creatorcontrib>Cayon, Jérôme</creatorcontrib><creatorcontrib>Riou, Jérémie</creatorcontrib><creatorcontrib>Saulnier, Patrick</creatorcontrib><creatorcontrib>Marleau, Sylvie</creatorcontrib><creatorcontrib>Roullin, V. Gaëlle</creatorcontrib><creatorcontrib>Hildgen, Patrice</creatorcontrib><creatorcontrib>Bastiat, Guillaume</creatorcontrib><title>Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells</title><title>European journal of pharmaceutics and biopharmaceutics</title><addtitle>Eur J Pharm Biopharm</addtitle><description>[Display omitted]
Polymer nanoparticles (NPs) are extensively studied as drug delivery systems for various therapeutic indications, including drug and imaging agent delivery to the brain. Despite intensive research, their toxicological profile has yet to be fully characterized. In particular, the more subtle effects of nanomaterials on inflammatory processes have scarcely been investigated. Surface properties of NPs are amongst parameters governing interactions between living cells and NPs. They could considerably influence the toxicity and inflammatory response of the cells exposed to NPs.
Polymeric NPs investigated here present a core-shell structure. The core is constituted of hydrophobic poly(lactic acid) (PLA) block and the surface is composed of a shell of hydrophilic block of polyethylene glycol (PEG). The effect of PEG chain length coating on the expression of genes involved in the inflammation response was investigated in two vascular endothelial cell lines (bEnd.3 and HUVEC) by qPCR. Moreover, ROS generation following NP uptake was evaluated.
PEGylated NPs induce a mild and transient activation of inflammatory cytokine and chemokine genes. However, differences in PEG chain length did not show any significant effect on cytokine and chemokine gene expression and PEGylated NPs did not trigger ROS generation.
The present results could contribute significantly to a deeper understanding of nanomaterial interactions and toxicity with vascular endothelial cells, guiding scientists in material coating choices.</description><subject>bEnd.3</subject><subject>Chemical Sciences</subject><subject>Chemokine</subject><subject>Cytokine</subject><subject>Cytokines</subject><subject>Drug Delivery Systems</subject><subject>Endothelial Cells - metabolism</subject><subject>Galenic pharmacology</subject><subject>HUVEC</subject><subject>Life Sciences</subject><subject>Nanoparticles - chemistry</subject><subject>Particle Size</subject><subject>PEG-PLA nanoparticle</subject><subject>Pharmaceutical sciences</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Polymers</subject><subject>Polymers - chemistry</subject><subject>Reactive Oxygen Species</subject><issn>0939-6411</issn><issn>1873-3441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFr3DAQhUVpabZp_0APRcf2YHdkyfIKegkhTQIL7SE9C600arTIlivZC_vvY7NpjjkNzHzvMbxHyGcGNQMmvx9qPIz7uoGmqUHUAPwN2bBtxysuBHtLNqC4qqRg7IJ8KOUAAKJrt-_JBW8F4wL4hvgHE2LKYfhLf9_cnqKZ0NHBDGk0eQo2Ii1z9sYi7ZOb13OhYfDR9L2ZUj7RjGVMQ8FlS4-m2IXJFAeXpkeMwURqMcbykbzzJhb89DwvyZ-fNw_Xd9Xu1-399dWusoKLqZKWA3eN7LyCxgI0XCFHabu2Va7d8r2QngkEr2Rr9sor54yyLVey8YAW-CX5dvZ9NFGPOfQmn3QyQd9d7fS6Ay5Fx7vuyBb265kdc_o3Y5l0H8r6rRkwzUU3UiiltqzlC9qcUZtTKRn9izcDvXahD3rtQq9daBB66WIRfXn2n_c9uhfJ__AX4McZwCWRY8Csiw04WHQho520S-E1_yfNjZs-</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Tehrani, Soudeh F.</creator><creator>Rabanel, Jean-Michel</creator><creator>Legeay, Samuel</creator><creator>Cayon, Jérôme</creator><creator>Riou, Jérémie</creator><creator>Saulnier, Patrick</creator><creator>Marleau, Sylvie</creator><creator>Roullin, V. Gaëlle</creator><creator>Hildgen, Patrice</creator><creator>Bastiat, Guillaume</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-5393-995X</orcidid></search><sort><creationdate>20220501</creationdate><title>Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells</title><author>Tehrani, Soudeh F. ; Rabanel, Jean-Michel ; Legeay, Samuel ; Cayon, Jérôme ; Riou, Jérémie ; Saulnier, Patrick ; Marleau, Sylvie ; Roullin, V. Gaëlle ; Hildgen, Patrice ; Bastiat, Guillaume</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-6c303d267f902c00239e3e6c7559d583b46f14e0f965ab9f9dda9c53962f0ec03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>bEnd.3</topic><topic>Chemical Sciences</topic><topic>Chemokine</topic><topic>Cytokine</topic><topic>Cytokines</topic><topic>Drug Delivery Systems</topic><topic>Endothelial Cells - metabolism</topic><topic>Galenic pharmacology</topic><topic>HUVEC</topic><topic>Life Sciences</topic><topic>Nanoparticles - chemistry</topic><topic>Particle Size</topic><topic>PEG-PLA nanoparticle</topic><topic>Pharmaceutical sciences</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Polymers</topic><topic>Polymers - chemistry</topic><topic>Reactive Oxygen Species</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tehrani, Soudeh F.</creatorcontrib><creatorcontrib>Rabanel, Jean-Michel</creatorcontrib><creatorcontrib>Legeay, Samuel</creatorcontrib><creatorcontrib>Cayon, Jérôme</creatorcontrib><creatorcontrib>Riou, Jérémie</creatorcontrib><creatorcontrib>Saulnier, Patrick</creatorcontrib><creatorcontrib>Marleau, Sylvie</creatorcontrib><creatorcontrib>Roullin, V. Gaëlle</creatorcontrib><creatorcontrib>Hildgen, Patrice</creatorcontrib><creatorcontrib>Bastiat, Guillaume</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tehrani, Soudeh F.</au><au>Rabanel, Jean-Michel</au><au>Legeay, Samuel</au><au>Cayon, Jérôme</au><au>Riou, Jérémie</au><au>Saulnier, Patrick</au><au>Marleau, Sylvie</au><au>Roullin, V. Gaëlle</au><au>Hildgen, Patrice</au><au>Bastiat, Guillaume</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells</atitle><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle><addtitle>Eur J Pharm Biopharm</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>174</volume><spage>155</spage><epage>166</epage><pages>155-166</pages><issn>0939-6411</issn><eissn>1873-3441</eissn><abstract>[Display omitted]
Polymer nanoparticles (NPs) are extensively studied as drug delivery systems for various therapeutic indications, including drug and imaging agent delivery to the brain. Despite intensive research, their toxicological profile has yet to be fully characterized. In particular, the more subtle effects of nanomaterials on inflammatory processes have scarcely been investigated. Surface properties of NPs are amongst parameters governing interactions between living cells and NPs. They could considerably influence the toxicity and inflammatory response of the cells exposed to NPs.
Polymeric NPs investigated here present a core-shell structure. The core is constituted of hydrophobic poly(lactic acid) (PLA) block and the surface is composed of a shell of hydrophilic block of polyethylene glycol (PEG). The effect of PEG chain length coating on the expression of genes involved in the inflammation response was investigated in two vascular endothelial cell lines (bEnd.3 and HUVEC) by qPCR. Moreover, ROS generation following NP uptake was evaluated.
PEGylated NPs induce a mild and transient activation of inflammatory cytokine and chemokine genes. However, differences in PEG chain length did not show any significant effect on cytokine and chemokine gene expression and PEGylated NPs did not trigger ROS generation.
The present results could contribute significantly to a deeper understanding of nanomaterial interactions and toxicity with vascular endothelial cells, guiding scientists in material coating choices.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35413403</pmid><doi>10.1016/j.ejpb.2022.04.003</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-5393-995X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0939-6411 |
ispartof | European journal of pharmaceutics and biopharmaceutics, 2022-05, Vol.174, p.155-166 |
issn | 0939-6411 1873-3441 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_03647377v1 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | bEnd.3 Chemical Sciences Chemokine Cytokine Cytokines Drug Delivery Systems Endothelial Cells - metabolism Galenic pharmacology HUVEC Life Sciences Nanoparticles - chemistry Particle Size PEG-PLA nanoparticle Pharmaceutical sciences Polyethylene Glycols - chemistry Polymers Polymers - chemistry Reactive Oxygen Species |
title | Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T01%3A19%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tailoring%20PEGylated%20nanoparticle%20surface%20modulates%20inflammatory%20response%20in%20vascular%20endothelial%20cells&rft.jtitle=European%20journal%20of%20pharmaceutics%20and%20biopharmaceutics&rft.au=Tehrani,%20Soudeh%20F.&rft.date=2022-05-01&rft.volume=174&rft.spage=155&rft.epage=166&rft.pages=155-166&rft.issn=0939-6411&rft.eissn=1873-3441&rft_id=info:doi/10.1016/j.ejpb.2022.04.003&rft_dat=%3Cproquest_hal_p%3E2649998153%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2649998153&rft_id=info:pmid/35413403&rft_els_id=S0939641122000753&rfr_iscdi=true |